-
Detailed Analysis Generate Full Report Add to Watchlist
Values as of: 2024-06-26
LEVI:NYE- (USD)
COMMON STOCK | Apparel Manufacturing |
Last Closing
USD 23.12Change
+0.12 (+0.52)%Market Cap
USD 9.16BVolume
6.75MVerdict
Verdict
Values as of: 2024-06-26
COMMON STOCK | Apparel Manufacturing |
Last Closing
USD 23.12Change
+0.12 (+0.52)%Market Cap
USD 9.16BVolume
6.75MVerdict
Verdict
Currency: USD
Country : USA
Symbol | Name | Price(Change) | Market Cap |
---|---|---|---|
RL | Ralph Lauren Corp Class A |
-0.81 (-0.46%) |
USD 11.53B |
PVH | PVH Corp |
-1.06 (-0.99%) |
USD 6.39B |
GIL | Gildan Activewear Inc. |
+0.01 (+0.03%) |
USD 6.38B |
VFC | VF Corporation |
-0.30 (-2.17%) |
USD 5.57B |
KTB | Kontoor Brands Inc |
+0.37 (+0.56%) |
USD 3.72B |
UA | Under Armour Inc C |
-0.13 (-1.95%) |
USD 2.99B |
ZGN | Ermenegildo Zegna NV |
+0.09 (+0.77%) |
USD 2.92B |
UAA | Under Armour Inc A |
-0.18 (-2.63%) |
USD 2.86B |
HBI | Hanesbrands Inc |
+0.09 (+1.86%) |
USD 1.74B |
OXM | Oxford Industries Inc |
+2.30 (+2.35%) |
USD 1.60B |
Symbol | Name | Weight | Mer | Price(Change) | Market Cap |
---|---|---|---|---|---|
EERN | 15.96 % | 0.00 % |
N/A |
N/A | |
LERN:LSE | 4.95 % | 0.00 % |
N/A |
N/A | |
LERN:F | 4.94 % | 0.00 % |
N/A |
N/A | |
LERN:XETRA | 4.94 % | 0.00 % |
N/A |
N/A | |
PXSG | Invesco S&P SmallCap Mome.. | 2.11 % | 0.39 % |
N/A |
N/A |
PACA | 0.27 % | 0.45 % |
N/A |
N/A | |
EES | WisdomTree U.S. SmallCap .. | 0.00 % | 0.38 % |
+0.56 (+0%) |
USD 0.58B |
ROSC | Hartford Multifactor Smal.. | 0.00 % | 0.00 % |
+0.46 (+0%) |
USD 0.03B |
Market Performance vs. Industry/Classification (Apparel Manufacturing) | Market Performance vs. Exchange | ||||||
Value | Sector Median | Percentile Rank | Grade | Market Median | Percentile Rank | Grade | |
YTD | |||||||
Capital Gain | 39.78% | 100% | F | 97% | N/A | ||
Dividend Return | 1.45% | 86% | B+ | 43% | F | ||
Total Return | 41.23% | 100% | F | 97% | N/A | ||
Trailing 12 Months | |||||||
Capital Gain | 61.23% | 100% | F | 96% | N/A | ||
Dividend Return | 3.35% | 88% | B+ | 49% | F | ||
Total Return | 64.57% | 100% | F | 96% | N/A | ||
Trailing 5 Years | |||||||
Capital Gain | 10.73% | 67% | D+ | 53% | F | ||
Dividend Return | N/A | N/A | N/A | N/A | N/A | ||
Total Return | 10.73% | 67% | D+ | 41% | F | ||
Average Annual (5 Year Horizon) | |||||||
Capital Gain | 8.88% | 60% | D- | 68% | D+ | ||
Dividend Return | 10.65% | 67% | D+ | 66% | D+ | ||
Total Return | 1.76% | 44% | F | 42% | F | ||
Risk Return Profile | |||||||
Volatility (Standard Deviation) | 49.30% | 60% | D- | 18% | F | ||
Risk Adjusted Return | 21.59% | 60% | D- | 45% | F | ||
Market Capitalization | 9.16B | 93% | A | 83% | B |
Target Price Action | Rating Action | Analyst | Rating | Price | Date |
---|
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
The company had positive total cash flow in the most recent four quarters.
The company had positive total free cash flow in the most recent four quarters.
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
The stock is trading high compared to its peers median on a price to book value basis.
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
The company has under performed its peers on annual average total returns in the past 5 years.
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
This stock has shown below median earnings growth in the previous 5 years compared to its sector
This stock has shown below median dividend growth in the previous 5 years compared to its sector.